Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC

Abstract Background Computed tomography (CT) is the standard procedure for follow-up of non-small-cell lung cancer (NSCLC) after radiochemotherapy. CT has difficulties differentiating between tumor, atelectasis and radiation induced lung toxicity (RILT). Diffusion-weighted imaging (DWI) may enable a...

Full description

Bibliographic Details
Main Authors: Jagoda Philippe, Fleckenstein Jochen, Sonnhoff Mathias, Schneider Günther, Ruebe Christian, Buecker Arno, Stroeder Jonas
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Cancer Imaging
Subjects:
Online Access:https://doi.org/10.1186/s40644-021-00384-9
_version_ 1818611865116213248
author Jagoda Philippe
Fleckenstein Jochen
Sonnhoff Mathias
Schneider Günther
Ruebe Christian
Buecker Arno
Stroeder Jonas
author_facet Jagoda Philippe
Fleckenstein Jochen
Sonnhoff Mathias
Schneider Günther
Ruebe Christian
Buecker Arno
Stroeder Jonas
author_sort Jagoda Philippe
collection DOAJ
description Abstract Background Computed tomography (CT) is the standard procedure for follow-up of non-small-cell lung cancer (NSCLC) after radiochemotherapy. CT has difficulties differentiating between tumor, atelectasis and radiation induced lung toxicity (RILT). Diffusion-weighted imaging (DWI) may enable a more accurate detection of vital tumor tissue. The aim of this study was to determine the diagnostic value of MRI versus CT in the follow-up of NSCLC. Methods Twelve patients with NSCLC stages I-III scheduled for radiochemotherapy were enrolled in this prospective study. CT with i.v. contrast agent and non enhanced MRI were performed before and 3, 6 and 12 months after treatment. Standardized ROIs were used to determine the apparent diffusion weighted coefficient (ADC) within the tumor. Tumor size was assessed by the longest longitudinal diameter (LD) and tumor volume on DWI and CT. RILT was assessed on a 4-point-score in breath-triggered T2-TSE and CT. Results There was no significant difference regarding LD and tumor volume between MRI and CT (p ≥ 0.6221, respectively p ≥ 0.25). Evaluation of RILT showed a very high correlation between MRI and CT at 3 (r = 0.8750) and 12 months (r = 0.903). Assessment of the ADC values suggested that patients with a good tumor response have higher ADC values than non-responders. Conclusions DWI is equivalent to CT for tumor volume determination in patients with NSCLC during follow up. The extent of RILT can be reliably determined by MRI. DWI could become a beneficial method to assess tumor response more accurately. ADC values may be useful as a prognostic marker.
first_indexed 2024-12-16T15:37:07Z
format Article
id doaj.art-2d4e7b76387a4d559b85abfaa425007b
institution Directory Open Access Journal
issn 1470-7330
language English
last_indexed 2024-12-16T15:37:07Z
publishDate 2021-01-01
publisher BMC
record_format Article
series Cancer Imaging
spelling doaj.art-2d4e7b76387a4d559b85abfaa425007b2022-12-21T22:26:09ZengBMCCancer Imaging1470-73302021-01-0121111110.1186/s40644-021-00384-9Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLCJagoda Philippe0Fleckenstein Jochen1Sonnhoff Mathias2Schneider Günther3Ruebe Christian4Buecker Arno5Stroeder Jonas6Clinic for Diagnostic and Interventional Radiology, Saarland University Medical CenterDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical CenterDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical CenterClinic for Diagnostic and Interventional Radiology, Saarland University Medical CenterDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical CenterClinic for Diagnostic and Interventional Radiology, Saarland University Medical CenterClinic for Diagnostic and Interventional Radiology, Saarland University Medical CenterAbstract Background Computed tomography (CT) is the standard procedure for follow-up of non-small-cell lung cancer (NSCLC) after radiochemotherapy. CT has difficulties differentiating between tumor, atelectasis and radiation induced lung toxicity (RILT). Diffusion-weighted imaging (DWI) may enable a more accurate detection of vital tumor tissue. The aim of this study was to determine the diagnostic value of MRI versus CT in the follow-up of NSCLC. Methods Twelve patients with NSCLC stages I-III scheduled for radiochemotherapy were enrolled in this prospective study. CT with i.v. contrast agent and non enhanced MRI were performed before and 3, 6 and 12 months after treatment. Standardized ROIs were used to determine the apparent diffusion weighted coefficient (ADC) within the tumor. Tumor size was assessed by the longest longitudinal diameter (LD) and tumor volume on DWI and CT. RILT was assessed on a 4-point-score in breath-triggered T2-TSE and CT. Results There was no significant difference regarding LD and tumor volume between MRI and CT (p ≥ 0.6221, respectively p ≥ 0.25). Evaluation of RILT showed a very high correlation between MRI and CT at 3 (r = 0.8750) and 12 months (r = 0.903). Assessment of the ADC values suggested that patients with a good tumor response have higher ADC values than non-responders. Conclusions DWI is equivalent to CT for tumor volume determination in patients with NSCLC during follow up. The extent of RILT can be reliably determined by MRI. DWI could become a beneficial method to assess tumor response more accurately. ADC values may be useful as a prognostic marker.https://doi.org/10.1186/s40644-021-00384-9TomographySpiral computedMagnetic resonance imagingFunctional magnetic resonance imagingRadiotherapyImage-guided
spellingShingle Jagoda Philippe
Fleckenstein Jochen
Sonnhoff Mathias
Schneider Günther
Ruebe Christian
Buecker Arno
Stroeder Jonas
Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC
Cancer Imaging
Tomography
Spiral computed
Magnetic resonance imaging
Functional magnetic resonance imaging
Radiotherapy
Image-guided
title Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC
title_full Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC
title_fullStr Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC
title_full_unstemmed Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC
title_short Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC
title_sort diffusion weighted mri improves response assessment after definitive radiotherapy in patients with nsclc
topic Tomography
Spiral computed
Magnetic resonance imaging
Functional magnetic resonance imaging
Radiotherapy
Image-guided
url https://doi.org/10.1186/s40644-021-00384-9
work_keys_str_mv AT jagodaphilippe diffusionweightedmriimprovesresponseassessmentafterdefinitiveradiotherapyinpatientswithnsclc
AT fleckensteinjochen diffusionweightedmriimprovesresponseassessmentafterdefinitiveradiotherapyinpatientswithnsclc
AT sonnhoffmathias diffusionweightedmriimprovesresponseassessmentafterdefinitiveradiotherapyinpatientswithnsclc
AT schneidergunther diffusionweightedmriimprovesresponseassessmentafterdefinitiveradiotherapyinpatientswithnsclc
AT ruebechristian diffusionweightedmriimprovesresponseassessmentafterdefinitiveradiotherapyinpatientswithnsclc
AT bueckerarno diffusionweightedmriimprovesresponseassessmentafterdefinitiveradiotherapyinpatientswithnsclc
AT stroederjonas diffusionweightedmriimprovesresponseassessmentafterdefinitiveradiotherapyinpatientswithnsclc